Barriers to medication entitlements after diagnosis of ADHD

Lancet Psychiatry. 2018 Jan;5(1):18-19. doi: 10.1016/S2215-0366(17)30468-6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity* / diagnosis
  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Attention Deficit Disorder with Hyperactivity* / economics
  • Attention Deficit Disorder with Hyperactivity* / epidemiology
  • Central Nervous System Stimulants* / economics
  • Central Nervous System Stimulants* / therapeutic use
  • Child
  • Communication Barriers*
  • Croatia / epidemiology
  • Drug Costs* / legislation & jurisprudence
  • Drug Costs* / standards
  • Health Services Accessibility*
  • Humans
  • Ireland / epidemiology
  • Mental Health Services / standards
  • Needs Assessment
  • Practice Patterns, Physicians' / economics
  • Prevalence

Substances

  • Central Nervous System Stimulants